छोड़कर सामग्री पर जाएँ

Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues

Revlimid sale contribution to US revenue likely to fall as it normalises, making for a muted December Quarter

Read More

​ Revlimid sale contribution to US revenue likely to fall as it normalises, making for a muted December Quarter Revlimid sale contribution to US revenue likely to fall as it normalises, making for a muted December Quarter  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी